Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats

Hoa Pham1, Gaelle Vottier1, Julien Pansiot1

  • 1INSERM, UMR 676, 75019 Paris, France; Université Paris Diderot, UFR de médecine Denis Diderot, Sorbonne Paris Cité, 75010 Paris, France; PremUP foundation, 75014 Paris, France.

Experimental Neurology
|December 11, 2013
PubMed

Insights

Inhaled nitric oxide (iNO) protected neonatal rats from white matter damage (WMD) caused by hyperoxia. While iNO improved brain injury, it had minimal effects on lung complications like bronchopulmonary dysplasia (BPD).

Area of Science:

  • Neonatal neurology
  • Pulmonary medicine
  • Developmental biology

Background:

  • White matter damage (WMD) and bronchopulmonary dysplasia (BPD) are critical complications in very preterm infants.
  • Inhaled nitric oxide (iNO) shows potential for promoting lung alveolarization and has demonstrated neuroprotective effects in neonatal brain injury models.

Purpose of the Study:

  • To investigate the neuroprotective effects of iNO in rat pups exposed to hyperoxia, mimicking conditions relevant to preterm infants.
  • To assess the impact of iNO on both white matter damage (WMD) and bronchopulmonary dysplasia (BPD) in a hyperoxia-induced injury model.

Main Methods:

  • Rat pups were exposed to hyperoxia (80% FiO2) or normoxia for 8 days, with concurrent treatment of iNO (5 ppm) or air.
  • Neurological and pulmonary outcomes were evaluated using histological, molecular, and behavioral assessments.
  • Specific markers for inflammation, cell death, oligodendrocyte proliferation/maturation, P27kip1, and BDNF were analyzed.

Main Results:

  • iNO significantly reduced hyperoxia-induced WMD by decreasing inflammation and cell death.
  • iNO promoted oligodendrocyte proliferation and maturation, alongside early upregulation of P27kip1 and BDNF.
  • Hyperoxia impaired associative learning, but iNO treatment preserved learning abilities comparable to controls.
  • iNO demonstrated only minor and transient improvements in BPD markers.

Conclusions:

  • Low-dose iNO exhibits specific neuroprotective properties in a preclinical model combining lung and brain injuries relevant to preterm birth complications.
  • iNO effectively mitigates white matter damage and preserves cognitive function in neonatal hyperoxia exposure.
  • The therapeutic benefits of iNO in this model are primarily neurological, with limited impact on pulmonary aspects of bronchopulmonary dysplasia.

Related Concept Videos